Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...] …
Category: Providers
With one outspoken critic of the 340B program and one key supporter set to hold influential positions in the new [...] …
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...] …
Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...] …
With just over half of the expected vote total counted, it’s too early to tell whether California voters will approve [...] …
Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] …
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...] …
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] …